Advertisement
Screener

Applied Therapeutics, Inc. Patents: Applications Rejected

Applied Therapeutics, Inc. Patent Applications Rejected

3 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-10-28: Application 18050627; Invention ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL DEHYDROGENASE DEFICIENCY; Applicant APPLIED THERAPEUTICS, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-08-05: Application 17428917; Invention METHODS FOR TREATING CUTANEOUS AGING; Applicant Applied Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2019-10-23: Application 16607644; Invention ALDOSE REDUCTASE INHIBITORS AND USES THEREOF; Applicant Applied Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2022-10-2818050627ALDOSE REDUCTASE INHIBITORS FOR TREATING SORBITOL DEHYDROGENASE DEFICIENCYAPPLIED THERAPEUTICS, INC.Abandoned -- Failure to Respond to an Office ActionUS20230121312A1
Shoshana SHENDELMAN
United States
MCMILLIAN, KARA RENITA
2021-08-0517428917METHODS FOR TREATING CUTANEOUS AGINGApplied Therapeutics, Inc.Abandoned -- Failure to Respond to an Office ActionUS20220071880A1
Shoshana SHENDELMAN
United States
WILSON, JERICA KATLYNN
2019-10-2316607644ALDOSE REDUCTASE INHIBITORS AND USES THEREOFApplied Therapeutics, Inc.Abandoned -- Failure to Respond to an Office ActionUS20200131203A1
Shoshana Shendelman
United States
WILLIS, DOUGLAS M